Discussions about stopping breast cancer screening in asymptomatic women 75 years and older are challenging for both physicians and women. Because randomized clinical trials that evaluated screening mammography excluded women in this age group, there are no empirical trial data that address whether screening women 75 years and older is beneficial. In this issue of JAMA Internal Medicine, Schonberg et al1 evaluated a decision aid to help older women decide whether to continue screening mammography. Most of the information conveyed in the decision aid studied by Schonberg and colleagues was based on evidence-based extrapolations from simulation modeling and was clearly presented. Women who were randomized to receive the decision aid were more knowledgeable about screening and more likely to discuss mammography with their primary care clinician. Almost all said that they would recommend it to others.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Elmore JG, Ngo-Metzger Q. The Life and Death of Mammograms in Patients 75 Years and Older—To Screen or Not to Screen? JAMA Intern Med. 2020;180(6):843–844. doi:10.1001/jamainternmed.2020.0431
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: